Distinguished in Hypothermia

Christian Rylander

Uppsala, C, SE 
Distinguished in Hypothermia
Uppsala, C, SE 
OverviewLocationsClinical Research

Overview

Christian Rylander practices in Uppsala, Sweden. Mr. Rylander is rated as a Distinguished expert by MediFind in the treatment of Hypothermia. His top areas of expertise are Cardiac Arrest, Hypothermia, Cerebral Hypoxia, Pulmonary Embolism, and Thrombectomy.

His clinical research consists of co-authoring 87 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 14 articles and participated in 1 clinical trial in the study of Hypothermia.

Gender
Male

Locations

Uppsala, C, Sweden
Other Locations
Goeteborg, O, Sweden
Lund, M, Sweden
Moelndal, O, Sweden
Centrum, C, Sweden

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Head Computed Tomography for Predicting Neurological Outcome After Cardiac Arrest- a TTM-2 Substudy
Head Computed Tomography for Predicting Neurological Outcome After Cardiac Arrest- a TTM-2 Substudy
Enrollment Status: Completed
Publish Date: March 22, 2024
Intervention Type: Diagnostic test
Neuropsychological Outcome After Cardiac Arrest: A Prospective Case Control Sub-study of the Targeted Hypothermia Versus Targeted Normothermia After out-of Hospital Cardiac Arrest Trial (TTM2)
Neuropsychological Outcome After Cardiac Arrest: A Prospective Case Control Sub-study of the Targeted Hypothermia Versus Targeted Normothermia After out-of Hospital Cardiac Arrest Trial (TTM2)
Enrollment Status: Completed
Publish Date: September 21, 2023
Intervention Type: Diagnostic test
Targeted Hypothermia Versus Targeted Normothermia After Out-of-hospital Cardiac Arrest (TTM2) - A Randomised Clinical Trial
Targeted Hypothermia Versus Targeted Normothermia After Out-of-hospital Cardiac Arrest (TTM2) - A Randomised Clinical Trial
Enrollment Status: Completed
Publish Date: April 03, 2023
Intervention Type: Procedure
Study Phase: Not Applicable
View 2 Less Clinical Trials

87 Total Publications

Blood biomarkers for the prediction of outcome after cardiac arrest: an international prospective observational study within the Targeted Hypothermia versus Normothermia after Out-of-Hospital Cardiac Arrest (TTM2) trial.
Blood biomarkers for the prediction of outcome after cardiac arrest: an international prospective observational study within the Targeted Hypothermia versus Normothermia after Out-of-Hospital Cardiac Arrest (TTM2) trial.
Journal: The Lancet. Respiratory medicine
Published: September 15, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Rylander's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile